专利信息

首页 1 2 3 下页尾页共 25 条记录, 当前第1/3页。

专利标题：Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors

The present invention provides a compound of formula I

专利标题：TOPICAL COMPOSITION

The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.

专利标题：Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases

A method of treatment of: i) HIV-1 infections in mammals, including humans

专利标题：ADSORPTION OF IMMUNOPOTENTIATORS TO INSOLUBLE METAL SALTS

Immunopotentiators can be adsorbed to insoluble metal salts, such as aluminium salts, to modify their pharmacokinetics, pharmacodynamics, intramuscular retention time, and/or immunostimulatory effect. Immunopotentiators are modified to introduce a moiety, such as a phosphonate group, which can mediate adsorption. These modified compounds can retain or improve their in vivo immunological activity even when delivered in an adsorbed form.

专利标题：PHARMACEUTICAL COMPOSITIONS

A pharmaceutical composition for the oral administration of a therapeutic compound of formula (I), comprising granules that comprise at least therapeutic compound of formula (I) or a tautomer thereof, or a pharmaceutically acceptable salt, or a hydrate or solvate thereof

专利标题：TABLET FORMULATIONS COMPRISING VALSARTAN

The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.

专利标题：Pharmaceutical Compositions Comprising Terbinafine

This invention provides a terbinafine pharmaceutical composition which is emulsifable or self-emulsifying or in form of an emulsion wherein the composition is adapted for oral administration.

专利标题：Transdermal therapeutic system for the administration of rivastigmine

专利标题：Stabilized Amorphous Forms of Imatinib Mesylate

The invention relates to the stabilized amorphous form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)-pyrimidin-2-ylamino)-pheny]-benzamide, pharmaceutical compositions such as capsules or tablets containing this form, the use of such form in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and the use of formulation principles stabilizing the amorphous form of Imatinib mesy...

专利标题：CRYSTALLINE FORMS OF THE SODIUM SALT OF (4--CYCLOHEXYL)-ACETIC ACID

The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates to processes for making such novel crystalline forms.

当前查询条件: [专利权人] 包含 ' NOVARTIS AG [CH]'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US2014088165A1	2014/3/27	US201314093956	2013/12/2
专利标题：Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors 专利权人：IWAKI YUKI [JP];KAWANAMI TOSHIO [US];KSANDER GARY MICHAEL [US];MOJI MUNETO [US];NOVARTIS AG [CH]; The present invention provides a compound of formula I

2. US2014045942A1	2014/2/13	US201314053176	2013/10/14
专利标题：TOPICAL COMPOSITION 专利权人：STEIGER MICHEL [CH];NOVARTIS AG [CH]; The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.

3. US2013281470A1	2013/10/24	US201313921233	2013/6/19
专利标题：Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases 专利权人：VERE HODGE RICHARD ANTHONY [GB];SCHINAZI RAYMOND [US];NOVARTIS AG [CH]; A method of treatment of: i) HIV-1 infections in mammals, including humans

4. US2013274465A1	2013/10/17	US201113820370	2011/9/1
专利标题：ADSORPTION OF IMMUNOPOTENTIATORS TO INSOLUBLE METAL SALTS 专利权人：SINGH MANMOHAN [US];SKIBINSKI DAVID A G [SG];WU TOM YAO-HSIANG [US];LI YONGKAI [US];CORTEZ ALEX [US];ZHANG XIAOYUE [US];ZOU YEFEN [US];HOFFMAN TIMOTHY Z [US];PAN JIANFENG [US];YUE KATHY [US];IRM LLC [BM];NOVARTIS AG [CH]; Immunopotentiators can be adsorbed to insoluble metal salts, such as aluminium salts, to modify their pharmacokinetics, pharmacodynamics, intramuscular retention time, and/or immunostimulatory effect. Immunopotentiators are modified to introduce a moiety, such as a phosphonate group, which can mediate adsorption. These modified compounds can retain or improve their in vivo immunological activity even when delivered in an adsorbed form.

5. US2013245061A1	2013/9/19	US201113989250	2011/12/1
专利标题：PHARMACEUTICAL COMPOSITIONS 专利权人：CAO YU [US];HACKL WOLFGANG [DE];LI PING [US];LI SHOUFENG [US];MIRZA TAHSEEN [US];ZEHENDER HARTMUT [FR];ZHU JIAHAO [US];NOVARTIS AG [CH]; A pharmaceutical composition for the oral administration of a therapeutic compound of formula (I), comprising granules that comprise at least therapeutic compound of formula (I) or a tautomer thereof, or a pharmaceutically acceptable salt, or a hydrate or solvate thereof

6. US2013237574A1	2013/9/12	US201213565977	2012/8/3
专利标题：TABLET FORMULATIONS COMPRISING VALSARTAN 专利权人：GANTER SABINA MARIA [DE];WAGNER ROBERT FRANK [US];NOVARTIS AG [CH]; The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.

7. US2013236514A1	2013/9/12
专利标题：Pharmaceutical Compositions Comprising Terbinafine 专利权人：BONNY JEAN-DANIEL [CH];EUGSTER ANDREAS CARL [CH];GUITARD PATRICE [FR];HIRSCH STEFAN [DE];NOVARTIS AG [CH]; This invention provides a terbinafine pharmaceutical composition which is emulsifable or self-emulsifying or in form of an emulsion wherein the composition is adapted for oral administration.

8. SI2292219T1	2013/8/30	SI20060031618T	2006/10/10
专利标题：Transdermal therapeutic system for the administration of rivastigmine 专利权人：LOHMANN THERAPIE SYST LTS [DE];NOVARTIS AG [CH];

9. US2013225598A1	2013/8/29	US201313864888	2013/4/17
专利标题：Stabilized Amorphous Forms of Imatinib Mesylate 专利权人：GONCALVES ELISABETE [CH];KALB OSKAR [CH];MUTZ MICHAEL [DE];WIRTH WOLFGANG [CH];LAKSHMAN JAY PARTHIBAN [US];NOVARTIS AG [CH]; The invention relates to the stabilized amorphous form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)-pyrimidin-2-ylamino)-pheny]-benzamide, pharmaceutical compositions such as capsules or tablets containing this form, the use of such form in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and the use of formulation principles stabilizing the amorphous form of Imatinib mesy...

10. US2013184311A1	2013/7/18	US201113876063	2011/10/5
专利标题：CRYSTALLINE FORMS OF THE SODIUM SALT OF (4--CYCLOHEXYL)-ACETIC ACID 专利权人：SUTTON PAUL ALLEN [US];GIRGIS MICHAEL J [US];LIANG JESSICA [US];PRASHAD MAHAVIR [US];VILLHAUER EDWIN BERNARD [US];NOVARTIS AG [CH]; The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethyl-pyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates to processes for making such novel crystalline forms.

下载范围

下载内容